Adenosine-5'-triphosphate (ATP) and ATP metabolites are involved in a myriad of biological processes 2 including cardiac function, neurotransmission, blood flow, and muscle contraction (Agteresch et al. 3 1999; Kushmerick and Conley 2002) , and it is strongly suggested that increased ATP levels correlate with 4 improved health and performance (Jordan et al. 2004; Herda et al. 2008; Swamy et al. 2011) . Direct 5 supplementation with exogenous ATP has produced mixed results in terms of increasing ATP when 6 measured in whole blood (Jordan et al. 2004; Arts et al. 2012; Burnstock et al. 2012) . Therefore, an 7 indirect approach for increasing endogenous ATP levels may be desirable. Previously, oral 8 supplementation with a proprietary blend of ancient peat and apple extracts has been demonstrated to 9 increase intracellular ATP levels in whole blood and muscle, suggesting increased activity of bodily 10 processes that produce or release endogenous ATP (Reyes-Izquierdo et al. 2013; Reyes-Izquierdo et al. 11 2014) . 12
Reyes-Izquierdo and colleagues (Reyes-Izquierdo et al. 2014) determined that a 150mg dose of this 13 blend of ancient peat and apple extracts significantly increased ATP in cellular fraction of blood 14 compared to placebo. Specifically, blood ATP increased by 40% 60 minutes following ingestion and 15 dropped to 28% 120 minutes following ingestion. A muscle biopsy was conducted in one resting subject, 16 and ATP levels in muscle tissue were observed to increase 281% at 60 minutes and 433% at 120 minutes 17 following ingestion (Reyes-Izquierdo et al. 2014) . Preliminary reports from this laboratory suggest this 18 occurs without increases in reactive oxygen species, which may be associated with increased ATP 19 production (Chang et al. 2010) . In fact, ancient peat and apple extracts may actually decrease reactive 20 oxygen species (Reyes-Izquierdo et al. 2013) , possibly blunting the increase in reactive oxygen species 21 caused by resistance training (Alessio et al. 2000) . 22 D r a f t Despite these observations, supplementation for indirect ATP enhancement is yet to be evaluated for 1 potential to induce body composition changes in response to resistance training. However, the existing 2 data on a blend of ancient peat and apple extracts for increasing both whole blood and muscle ATP 3 levels (Reyes-Izquierdo et al. 2013; Reyes-Izquierdo et al. 2014 ) support the plausibility that chronic 4 supplementation may yield changes in body composition. Additionally, because this is a novel 5 ingredient, chronic supplementation must be verified as safe. Therefore, the purpose of this study is to 6 determine the effects of a proprietary blend of ancient peat and apple extracts on body composition 7 and hematological safety markers. It was hypothesized that the supplement will increase lean muscle 8 mass and muscle hypertrophy without producing a change in body fat or hematological safety markers. 9
Methods 10
Participants 11
Twenty-five healthy, resistance-trained, male subjects (27.7 ± 4.8y; 176.0 ± 6.5cm; 83.2 ± 12.1kg) 12 completed this study. Thirty-three subjects were recruited, and three subjects did not complete the 13 study due to scheduling conflicts, three were not compliant with protocols, and two sustained injuries 14 during the study. Each subject was required to be capable of lifting 1.5x their bodyweight in the squat 15 and deadlift and 1x bodyweight in the bench press. At baseline, the placebo (PLA) group was able to 16 squat 1.71 ± 0.21, bench press 1.45 ± 0.19, and deadlift 2.17 ± 0.25 times their bodyweight, and the 17 treatment (TRT) group was able to squat 1.66 ± 0.24, bench press 1.31 ± 0.20, and deadlift 1.93 ± 0.27 18 times their bodyweight. Approval for research with human subjects was obtained from a registered IRB, 19 and subjects were provided with written informed consent documents prior to participation in the 20 study. 21
Experimental Design 22

D r a f t
Subjects were randomly assigned to either the PLA (n = 11) or TRT (n = 14) groups. They were instructed 1 to consume 1 serving of either PLA or TRT (elevATP®, VDF FutureCeuticals Inc., Momence, IL; 150mg) 45 2 minutes prior to training on training days or at a similar time of day on rest days (for detailed 3 supplement composition, see (Reyes-Izquierdo et al. 2013) ). Supplement vials were weighed to ensure 4 compliance. Both subjects and researchers were blinded to the PLA and TRT groups. The researchers 5 received two sets of supplements labeled A and B from a third-party manufacturer. The blind was 6 broken only after the completion of data analysis. Subjects were resistance trained under the guidance 7 of a certified strength and conditioning specialist 3 days per week for 8 weeks followed by a 2-week 8 overreach and 2-week taper phase corresponding to weeks 9-10 and 11-12, respectively, in a design 9 similar to that previously described (Wilson et al. 2013) . A eucaloric diet consisting of 50% calories from 10 carbohydrates, 25% from protein, and 25% from fat was prescribed to all subjects at the onset of the 11 study, and diets were tracked weekly via 3-day food logs. Total calories were determined for each bench press, deadlift, incline bench press, power squat, hammer strength isolateral bench press, leg 20 press, leg extension, leg curl, and triceps extension performed for 3 sets of 6-12 repetitions at 65-80% 21 1RM intensity, one power day consisting of barbell back squat, bench press, and deadlift performed for 22 5 sets of 2-5 repetitions at 40-60% 1RM intensity with a goal of high velocity of movement, and one 23 strength oriented day consisting of barbell back squat, bench press, deadlift, shoulder press, andD r a f t pulldown performed for 3 sets of 1-5 repetitions at 85-100% 1RM intensity. After performing the main 1 exercises on the power day, subjects performed bent over row, pulldown, dumbbell row, shoulder 2 press, lateral raise, and bicep curl exercises for the goal of muscle hypertrophy as described for chest 3 and leg exercises. Following the resistance exercises on the strength day, participants performed 2-6 4 sets of 10-30s Wingates with 2-4 minutes rest on a cycle ergometer. Participants rested 48-72 hours 5 between each training day, and 30-120s between sets on the hypertrophy day or 2-5min between sets 6 on the power and strength days. During the overreach phase, participants performed high volume 7 workouts, similar to the hypertrophy oriented workouts performed during weeks 1-8, on Monday 8 through Thursday with a strength-oriented workout or performance testing conducted on Friday for 9 weeks 9 and 10, respectively. The taper weeks consisted of one power day on Mondays then strength 10 and power day on both Wednesdays and Fridays performed at low volume for back squat, bench press, 11 and deadlift only. Each training cycle began with the lowest intensity of the range provided, and 12 intensity progressively increased as repetitions decreased and rest time increased from session to 13 session. 14
Measurements 15
Urine specific gravity was determined on each body composition testing day to ensure measurements 16 were conducted in a euhydrated state. Adequate hydration was considered to be a USG of 1.000 -17 1.030. On 3 occasions, a participant was required to drink water until another urine sample could be 18 submitted and verified for adequate hydration status. Body weight was determined using a calibrated 19 column scale (SECA, Chino, CA). Body composition was analyzed for whole-body LST, FM, and BF% as 20 well as segmental LST using DEXA (Lunar Prodigy Primo, General Electric, Fairfield, CN) using enCORE 21 software (Version 15, Madison, WN). Test-retest reliability for DEXA LST, BF%, and FM, as measured 22 using 15 subjects, resulted in an average ICC of >0.99. CSA, MT, and FT were determined using 23 ultrasound (Logiq e, General Electric, Fairfield, CN). Ultrasonography determined CSA was measured atD r a f t 75% femur length, as defined as the distance from the anterior superior iliac spine to the superior aspect 1 of the patella. MT of the quadriceps was measured at 50% femur length, defined as the distance from 2 the greater trochanter of the femur to the lateral epicondyle of the femur. MT was defined as the 3 combined thickness of the vastus lateralis and vastus intermedius. The distance from the superficial 4 aspect the femur to the deep aspect of the superficial fascia of the vastus lateralis was measured. FT 5 was measured at the same site as MT, and it was defined as the distance from the superficial aspect of 6 the vastus lateralis fascial layer to the deep aspect of the hypodermis. Test-retest reliability for 7 ultrasound measurements, as determined using 5 subjects, resulted in an average ICC >0.99. Vital signs 8
were determined using an automated, digital sphygmomanometer (Omron Corporation, Kyoto, Japan). 9
Blood draws were performed via venipuncture by a trained phlebotomist. Following a 10-hour fast, all 10 subjects submitted a blood sample for analysis in the morning to control for diurnal variations. Corporation of America, Denver, CO). Inter-test reliability results from 12 men and women measured up 22 to one week apart at the aforementioned laboratory resulted in no significant differences from day-to-23 day (p > 0.05) and an average inter-test Coefficient of Variation of 6.9% for all tests.
D r a f t
Statistical Analyses 1
A repeated measures ANOVA was performed to assess group, time, and group x time interactions with a 2 significant p-value considered as <0.05. Bonferroni post-hoc analyses were used to locate differences 3 following a significant group x time interaction. Dependent T-test were conducted to determine within-4 group time effects for all body composition variables and hematology variables with a significant 5 interaction. On two occasions, a dependent variable was significantly different between groups at 6 baseline, and ANCOVAs were performed to assess group, time, and group x time interactions. 7 Independent T-tests were conducted on the delta values for each time point. Statistica (Version 10, 8
Statsoft, Tulsa, OK) was used for all statistical analyses. 9
Results 10 A significant main effect for time and a group x time (p < 0.05) interaction (observed power > 0.99) was 11 present for CSA. CSA was significantly increased in TRT versus PLA at weeks 8, 10, and 12 (Table 1) . 12
Moreover, CSA increased in TRT compared to PLA between all time points except for between weeks 0 13 and 4 using independent T-tests (p < 0.05; Figure 1 ). There was a significant main effect for time and a 14 group x time (p < 0.05) interaction (observed power = 0.92) observed for MT (Figure 2 , Table 1 ). 15
Wherein, MT increased to a greater extent in TRT than PLA from pre to weeks 10 and 12. A significant 16 main effect for time (p < 0.05) was found for body weight, FT, LST, FM, BF%, and LST of the arms, legs, 17 and trunk, but no significant group x time interactions existed for these variables (Table 1) . 18
No changes were observed for systolic or diastolic blood pressure or heart rate. A significant group x 19 time (p < 0.05) interaction (observed power = 0.89) was present for creatinine, which increased from pre 20 to post in both TRT and PLA (TRT: +0.06; PLA: +0.15mg/dL). There was a significant group x time (p < 21 0.05) effect (observed power = 0.89) for triglycerides from pre to post (TRT: +24.1; PLA: -20.2mg/dL). 22
Finally, a significant group x time (p < 0.05) interaction (observed power = 0.89) existed for VLDL from 23 D r a f t pre to post (TRT: +4.9; PLA: -3.9mg/dL). However, differences were present for triglycerides and VLDL at 1 baseline. Further analysis using ANCOVA revealed no significant difference for triglycerides (p = 0.09) or 2 VLDL (p = 0.11). No other significant interactions were observed for any safety markers, and each 3 marker remained within the physiological reference range (Tables 2, 3, and 4) . 4
Discussion 5 The results of this study support the hypotheses. Although no interactions were observed for any 6 measurement of LST between groups, both CSA and MT increased while measures of body fat content 7 and body weight were unchanged. In the PLA group, CSA tended to decline following the overreach and 8 taper phases, while TRT increased. We hypothesize that the PLA group was unable to adapt to the 9 overreach stimulus, whereas the supplement aided this adaptation. Moreover, no abnormal changes in 10 vital signs or blood markers were detected. Creatinine increased to a greater extent in PLA compared to 11 TRT, and PLA had elevated triglycerides and VLDL at baseline versus TRT, which appeared to normalize 12 throughout the trial. Furthermore, each blood marker remained within the clinical reference range. 13
With these considerations, it is unlikely that these changes were produced by supplementation. 14 Previous reports on direct ATP supplementation and resistance training are in agreement with the 15 present results. Wherein, muscle mass increased without changes in fat mass (Wilson et al. 2013) . 16
Although it has also been reported that 12 weeks of direct ATP supplementation is safe (Wilson et al. This is the first study examining the effects of indirect ATP enhancement with supplementation on body 3 composition. Daily supplementation with a proprietary blend of ancient peat and apple extracts may be 4 beneficial for enhancing the hypertrophic effects of resistance training on skeletal muscle without 5 augmenting body fat content or safety parameters. Therefore, strength athletes, bodybuilders, and 6 contact sport athletes may have an interest using this supplement. It is possible that this effect is 7 exerted via increased blood flow, anabolic signaling, and/or enhanced energy status. However, future 8 research is necessary to elaborate on the mechanisms of the present observations, and possibly in a 9
younger versus older population. Future research may also be interested in determining the combined 10 effects of a blend of ancient peat and apple extracts with creatine and/or nitrate, as both are thought to 11 affect ATP availability. 12 D r a f t 
